Chiral Cu(I) Complex for Enantioselective Hydroboration

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

The development of highly regio- and enantioselective Markovnikov hydroboration of unactivated terminal olefins remains a challenging task, with existing methods offering limited enantioselectivity, particularly in the use of Rh-catalyzed asymmetric hydroboration which achieves only 72-90% enantiomeric excess.

Innovation Solution

The synthesis of air and moisture-stable chiral 1,3-diarylimidazole salt carbene precursors, specifically a Cu(I) complex, is used to facilitate highly regio- and enantioselective Markovnikov hydroboration of unactivated terminal alkenes, forming chiral boronic esters, and potentially applied in various metal-catalyzed asymmetric transformations.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Manufacturing precision

If Rh-catalyzed asymmetric hydroboration is used, then the reaction can proceed, but the enantioselectivity is limited to 72-90% ee

Engineering Contradiction:
ImproveenantioselectivityVSAvoidcatalyst complexity
Core Design Contradiction:
Manufacturing precisionVSDevice complexity

Solution Approach 1:

The patent changes the metal center parameter from Rhodium to Copper, and modifies the ligand parameters by using chiral 1,3-diarylimidazole-2-ylidene ligands with specific structural features (aromatic substituents at positions 4 and 6). These parameter changes in the catalyst composition result in significantly improved enantioselectivity (92-98% ee) compared to the previously used Rh-catalyzed system (72-90% ee).

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent creates a composite catalyst system by combining Cu(I) metal center with chiral 1,3-diarylimidazole-2-ylidene ligands. This composite catalyst structure, where the copper ion coordinates with the nitrogen atoms of the imidazole ring and the chiral information from the aromatic substituents, produces a synergistic effect that achieves superior enantioselectivity beyond what either component could achieve alone.

Inventive Principle:
Principle #40Composite materials

2Manufacturing precision

If chiral NHC ligands are used to improve enantioselectivity, then the catalytic activity increases, but the synthesis complexity of the ligand increases

Engineering Contradiction:
ImproveenantioselectivityVSAvoidligand synthesis ease
Core Design Contradiction:
Manufacturing precisionVSEase of manufacture

Solution Approach 1:

The ligand synthesis is divided into separate modular steps: first synthesizing the chiral building blocks (compounds of formula 1 with specific substituents R1-R6), then condensing these with carbonyl compounds to form the imidazole ring system. This segmentation allows for systematic optimization of each step and simplifies the overall synthesis pathway while maintaining high enantioselectivity.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The patent prepares the chiral 1,3-diarylimidazole-2-ylidene ligands in advance and characterizes them before use in catalysis. The ligands are synthesized with pre-installed chiral centers and aromatic substituents that will determine the stereochemical outcome. This preliminary preparation and characterization of the chiral ligands enables their direct application in catalytic reactions without requiring further modification during the catalytic process.

Inventive Principle:
Principle #10Preliminary action

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The chiral 1,3-diarylimidazole carbene precursor Cu(I) complex achieves high regio- and enantioselectivity in hydroboration reactions, improving upon existing methods by enhancing enantioselectivity and expanding its application in asymmetric catalytic processes.

Implementation Method 1

An air and moisture stable chiral 1, 3-diarylimidazole carbene precursor Cu (I) complex has been prepared and applied to highly regio- and enantioselective Markovnikov hydroboration of unactivated terminal alkenes

Methodology Applied
Scientific EffectCatalysis: Catalysis

Data Source

PatentUS11345665B2Chiral 1,3-diarylimidazolium salt carbene precursor, synthesis method therefor, metal salt compound and application thereof
Publication Date: 2022.05.31 SHANGHAI INST OF ORGANIC CHEM CHINESE ACAD OF SCI
  • US11345665B2 patent drawing
  • US11345665B2 patent drawing
  • US11345665B2 patent drawing

AI summary

Chiral 1, 3-diarylimidazole salt carbene precursors, their methods of preparation, particularly transition metal complexes and their use in chemical synthesis are provided. In particular, an air and moisture stable chiral 1, 3-diarylimidazole carbene precursor Cu (I) complex has been prepared and applied to highly regio- and enantioselective Markovnikov hydroboration of unactivated terminal alkenes to form chiral boronic esters. Moreover, these new chiral NHCs can be potentially applied in various metal-catalyzed asymmetric transformations.